Product NDC: | 0002-8400 |
Proprietary Name: | Forteo |
Non Proprietary Name: | Teriparatide |
Active Ingredient(s): | 250 ug/mL & nbsp; Teriparatide |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-8400 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021318 |
Marketing Category: | NDA |
Start Marketing Date: | 20081001 |
Package NDC: | 0002-8400-99 |
Package Description: | 1 SYRINGE in 1 CARTON (0002-8400-99) > 2.4 mL in 1 SYRINGE |
NDC Code | 0002-8400-99 |
Proprietary Name | Forteo |
Package Description | 1 SYRINGE in 1 CARTON (0002-8400-99) > 2.4 mL in 1 SYRINGE |
Product NDC | 0002-8400 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Teriparatide |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20081001 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | TERIPARATIDE |
Strength Number | 250 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Parathyroid Hormone [Chemical/Ingredient],Parathyroid Hormone Analog [EPC] |